Citations

Showing 10 of 108152 citations.

Is the Childless Pediatrician Less Confident? Assessment of Physician Confidence in Providing Parenting Advice and Introduction of a Novel Approach to Anticipatory Guidance Training
Corredor, Margarita , Thorvilson, Megan J. , Ristagno, Elizabeth H. , Pittock, Siobhán T. , Kellund, Anna , Homme, Jason H. , Creo, Ana L. , Corredor, Margarita M , Thorvilson, Megan, Pittock, Siobhan , Homme, Jason, Creo, Ana

Mayo Clinic

Clinical Pediatrics | August 21, 2021 | Volume: 60 | Issue: 11-12 | Pages: 447-451

10.1177/00099228211039951 | PMID 34416836 Get It

Bronchoalveolar Lavage Lymphocytosis in Hypersensitivity Pneumonitis: A Retrospective Cohort Analysis with Elimination of Incorporation Bias
Hill, Meghan , Moua, Teng , Petnak, Tananchai

Mayo Clinic

No container title available | August 20, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-825300/v1 Get It

Abstract Background: Recent studies support the diagnostic role of bronchoalveolar lavage lymphocytosis (BALL) in patients with suspected hypersensitivity pneumonitis (HP). Our study aim was to determine the spectrum of BALL findings with elimination of incorporation bias and assess correlates of positive BALL cut-off and BALL association with long-term outcomes in those with fibrotic disease (f-HP).Methods: A single-center retrospective cohort study was pursued of patients undergoing diagnostic bronchoscopy for interstitial lung disease. Strict study enrollment was based on recent ATS/JRS/ALAT diagnostic guidance meeting ‘moderate’ or higher diagnostic confidence. BALL findings were assessed in both fibrotic and non-fibrotic HP patients with regression and survival analysis pursued for correlates of positive BALL cut-off and long-term outcome. Results: A total of 148 patients (88 fibrotic and 60 non-fibrotic) meeting moderate or higher diagnostic confidence were included. Median BALL in f-HP was 15% compared to 19% in non-fibrotic patients, with only 28% of f-HP meeting diagnostic cut-off (≥ 30%) compared to 41% of non-fibrotic. For f-HP, centrilobular nodules on computed tomography was positively correlated with a diagnostic BALL (OR 4.07; p = 0.018) while honeycombing was negatively correlated (OR 6.9 x e-8; p = 0.001). Higher BALL was also associated with lower all-cause mortality (HR 0.98; p = 0.015). Conclusion: With elimination of incorporation bias, most patients with well-described HP did not meet diagnostic BALL thresholds. Higher BALL was associated with better long-term survival in those with fibrosis, but its diagnostic role may be more additive than characteristic or distinguishing.
Comparative Analyses of Three Point-of-Care Urine Drug Test Devices’ Performance Characteristics for Use in Ambulatory Clinic Settings
Waggoner, Derek C. , Delaney, Sarah , Korpi‐Steiner, Nichole , Delaney, Sarah R, Delaney, Sarah R

Mayo Clinic

The Journal of Applied Laboratory Medicine | August 20, 2021 | Volume: 7 | Issue: 2 | Pages: 495-502

10.1093/jalm/jfab095 | PMID 34597363 Get It

Abstract Background Urine drug testing (UDT) is a standard practice used for monitoring controlled and illicit substances in ambulatory care patients. Point-of-care (POC) UDTs are useful tools that allow for drug identification within minutes, providing rapid and objective diagnostic assistance for clinicians. The objective of this study was to evaluate the performance characteristics of 3 different POC UDT devices compared to reference methods. Methods A total of 106 residual urine specimens were collected to evaluate the 3 POC UDT devices: the Profile®-V MEDTOX Scan® drugs of abuse test, Quidel Triage® TOX Drug screen, and Quidel Triage Rapid OXY-BUP-MDMA panel. Device performance was assessed by their ability to identify drug classes/compounds compared to manufacturer and reference method (mass spectrometry) cutoffs. Results The results from quantitative mass spectrometry showed that 77% (84/106) of the samples were positive for one or more drugs. Each device had variable performance across each drug class. Overall, the specificity of the Profile-V MEDTOX Scan test was 90.1%, while the Quidel Triage TOX Drug Screen and Rapid OXY-BUP-MDMA devices had specificities of 89.0% and 50.0% using their respective manufacturer-stated cutoffs. Overall sensitivity was determined to be 98.6%, 97.0%, and 100% for the Profile-V MEDTOX Scan, Quidel Triage TOX Drug Screen, and Rapid OXY-BUP-MDMA, respectively. Conclusions Of the 3 POC UDT devices evaluated, the Profile-V MEDTOX Scan demonstrated the best overall sensitivity and specificity compared to reference methods. False positive and negative results are possible with UDTs, ultimately the best device may depend on patient population and drugs of interest.
Recommendations for Donor and Recipient Selection and Risk Prediction: Working Group Report From the ILTS Consensus Conference in DCD Liver Transplantation
Schlegel, Andrea , Foley, David P. , Carvalho, Mauricio Flores , Carlis, Luciano De , Heaton, Nigel , Taner, C. Burcin , Savier, Éric , Schlegel, Andrea

Mayo Clinic

Transplantation | August 20, 2021 | Volume: 105 | Issue: 9 | Pages: 1892-1903

10.1097/tp.0000000000003825 | PMID 34416750 Get It

Although the utilization of donation after circulatory death donors (DCDs) for liver transplantation (LT) has increased steadily, much controversy remains, and no common acceptance criteria exist with regard to donor and recipient risk factors and prediction models. A consensus conference was organized by International Liver Transplantation Society on January 31, 2020, in Venice, Italy, to review the current clinical practice worldwide regarding DCD-LT and to develop internationally accepted guidelines. The format of the conference was based on the grade system. International experts in this field were allocated to 6 working groups and prepared evidence-based recommendations to answer-specific questions considering the currently available literature. Working group members and conference attendees served as jury to edit and confirm the final recommendations presented at the end of the conference by each working group separately. This report presents the final statements and recommendations provided by working group 2, covering the entire spectrum of donor and recipient risk factors and prediction models in DCD-LT.
The Lebanese healthcare sector: The point of exsanguination
Saliba, Antoine N. , Taher, Alì , Saliba, Antoine N. , Taher, Ali T , Saliba, Antoine N , Saliba, Antoine N

Mayo Clinic

American Journal of Hematology | August 20, 2021 | Volume: 96 | Issue: 11 | Pages: No page available

10.1002/ajh.26331 | PMID 34416043 Get It

NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021
Abu‐Rustum, Nadeem R. , Yashar, Catheryn M. , Bradley, Kristin , Campos, Susana M. , Chino, Junzo , Chon, Hye Sook, Damast, Shari , Diver, Elisabeth , Fisher, Christine M. , Frederick, Peter J., Gaffney, David K. , Giuntoli, Robert , Han, Ernest , Howitt, Brooke E. , Huh, Warner K. , Mariani, Andrea , Nekhlyudov, Larissa , Podoll, Mirna, Remmenga, Steven W., Reynolds, R. Kevin, Salani, Ritu , Sisodia, Rachel , Soliman, Pamela T. , Ueda, Stefanie , Urban, Renata R. , Wyse, Emily , Zanotti, Kristine , McMillian, Nicole R., Motter, Angela D., Chu, Christina , Cohn, David E. , Crispens, Marta Ann , George, Suzanne , Lea, Jayanthi Sivasothy , Mutch, David G. , Tanner, Edward J. , Wethington, Stephanie L.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | August 20, 2021 | Volume: 19 | Issue: 8 | Pages: 888-895

10.6004/jnccn.2021.0038 | PMID 34416706 Get It

The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.
Wilms Tumor (Nephroblastoma), Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Anderson, Clarke, Cook, Shelly, Gow, Kenneth W. , Hiniker, Susan M. , Jasty‐Rao, Rama, Lin, Chi , Lovvorn, Harold N. , MacEwan, Iain, Martínez-Agosto, Julián A. , Mullen, Elizabeth A. , Murphy, Erin S. , Ranalli, Mark , Rhee, Daniel S. , Tracy, Elisabeth T. , Vern-Gross, T.Z., Walsh, Michael F. , Wickiser, Jonathan E., Zapala, Matthew A. , Berardi, Ryan A., Hughes, Miranda, Vern-Gross, Tamara, Tracy, Elisabeth T , Balis, Frank M. , Green, Daniel M. , Dhillon, Jasreman , Rokitka, Denise A. , Walz, Amy L.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | August 20, 2021 | Volume: 19 | Issue: 8 | Pages: 945-977

10.6004/jnccn.2021.0037 | PMID 34416707 Get It

The NCCN Guidelines for Wilms Tumor focus on the screening, diagnosis, staging, treatment, and management of Wilms tumor (WT, also known as nephroblastoma). WT is the most common primary renal tumor in children. Five-year survival is more than 90% for children with all stages of favorable histology WT who receive appropriate treatment. All patients with WT should be managed by a multidisciplinary team with experience in managing renal tumors; consulting a pediatric oncologist is strongly encouraged. Treatment of WT includes surgery, neoadjuvant or adjuvant chemotherapy, and radiation therapy (RT) if needed. Careful use of available therapies is necessary to maximize cure and minimize long-term toxicities. This article discusses the NCCN Guidelines recommendations for favorable histology WT.
Characterization of Nonphysician Health Care Workers’ Burnout and Subsequent Changes in Work Effort
Major‐Elechi, Brittny , Thapa, Prabin , Fraser, Cathryn H., Buskirk, Steven J., Dyrbye, Liselotte N. , Major-Elechi, Brittny, Hays, J. Taylor , West, Colin P.

Mayo Clinic

JAMA Network Open | August 20, 2021 | Volume: 4 | Issue: 8 | Pages: e2121435

10.1001/jamanetworkopen.2021.21435 | PMID 34415312 Get It

Risk Factors for Critical Coronavirus Disease 2019 and Mortality in Hospitalized Young Adults: An Analysis of the Society of Critical Care Medicine Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS) Coronavirus Disease 2019 Registry
Sayed, Imran A., Dapul, Heda , McGarvey, Jeremy , Bandy, Jennifer A., Boman, Karen , Kumar, Vishakha K. , Bansal, Vikas , Retford, Lynn, Kaufman, Margit, Heavner, Smith F. , Danesh, Valerie , Hill, Catherine A. St., Bhalala, Utpal , Koritala, Thoyaja , Заболотских, И. Б. , Asghar, Muhammad Sohaib , Iwasaki, Yudai , Tarabichi, Yasir , Bansal, Vikas , Asghar, Muhammad S , Tripathi, Sandeep , Cheruku, Sreekanth , Khanna, Ashish K. , Kashyap, Rahul , Gajic, Ognjen , Walkey, Allan J. , Gist, Katja M.

Mayo Clinic

Critical Care Explorations | August 20, 2021 | Volume: 3 | Issue: 8 | Pages: e0514

10.1097/cce.0000000000000514 | PMID 34476401 Get It

IMPORTANCE: Even with its proclivity for older age, coronavirus disease 2019 has been shown to affect all age groups. However, there remains a lack of research focused primarily on the young adult population. OBJECTIVES: To describe the epidemiology and outcomes of coronavirus disease 2019 and identify the risk factors associated with critical illness and mortality in hospitalized young adults. DESIGN, SETTINGS, AND PARTICIPANTS: A retrospective cohort study of the Society of Critical Care Medicine’s Viral Infection and Respiratory Illness Universal Study registry. Patients 18–40 years old, hospitalized from coronavirus disease 2019 from March 2020 to April 2021, were included in the analysis. MAIN OUTCOMES AND MEASURES: Critical illness was defined as a composite of mortality and 21 predefined interventions and complications. Multivariable logistic regression was used to assess associations with critical illness and mortality. RESULTS: Data from 4,005 patients (152 centers, 19 countries, 18.6% non-U.S. patients) were analyzed. The median age was 32 years (interquartile range, 27–37 yr); 51% were female, 29.4% Hispanic, and 42.9% had obesity. Most patients (63.2%) had comorbidities, the most common being hypertension (14.5%) and diabetes (13.7%). Hospital and ICU mortality were 3.2% (129/4,005) and 8.3% (109/1,313), respectively. Critical illness occurred in 25% (n = 996), and 34.3% (n = 1,376) were admitted to the ICU. Older age (p = 0.03), male sex (adjusted odds ratio, 1.83 [95% CI, 1.2–2.6]), and obesity (adjusted odds ratio, 1.6 [95% CI, 1.1–2.4]) were associated with hospital mortality. In addition to the above factors, the presence of any comorbidity was associated with critical illness from coronavirus disease 2019. Multiple sensitivity analyses, including analysis with U.S. patients only and patients admitted to high-volume sites, showed similar risk factors. CONCLUSIONS: Among hospitalized young adults, obese males with comorbidities are at higher risk of developing critical illness or dying from coronavirus disease 2019.
Faculty Opinions recommendation of An isoform of Dicer protects mammalian stem cells against multiple RNA viruses.
Liu, Qiuying , Hu, Wenqian

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | August 20, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.740443701.793587589 Get It